Plancorp LLC’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $361K | Sell |
1,726
-28
| -2% | -$5.36K | 0.01% | 304 |
|
|
2026
Q1 | $303K | Buy |
1,754
+17
| +1% | +$3.13K | 0.01% | 286 |
|
|
2025
Q4 | $306K | Buy |
1,737
+141
| +9% | +$23K | 0.01% | 284 |
|
|
2025
Q3 | $224K | Sell |
1,596
-11
| -0.7% | -$1.49K | 0.01% | 342 |
|
|
2025
Q2 | $202K | Buy |
1,607
+20
| +1% | +$2.49K | 0.01% | 355 |
|
|
2025
Q1 | $217K | Buy |
1,587
+65
| +4% | +$9.29K | 0.01% | 332 |
|
|
2024
Q4 | $233K | Sell |
1,522
-27
| -2% | -$4.55K | 0.01% | 287 |
|
|
2024
Q3 | $300K | Sell |
1,549
-54
| -3% | -$11.3K | 0.01% | 251 |
|
|
2024
Q2 | $372K | Sell |
1,603
-3
| -0.2% | -$652 | 0.02% | 208 |
|
|
2024
Q1 | $346K | Sell |
1,606
-63
| -4% | -$14.8K | 0.02% | 213 |
|
|
2023
Q4 | $432K | Buy |
1,669
+123
| +8% | +$30.2K | 0.02% | 180 |
|
|
2023
Q3 | $397K | Buy |
1,546
+10
| +0.7% | +$2.67K | 0.02% | 173 |
|
|
2023
Q2 | $438K | Hold |
1,536
| – | – | 0.02% | 157 |
|
|
2023
Q1 | $427K | Sell |
1,536
-2
| -0.1% | -$553 | 0.02% | 166 |
|
|
2022
Q4 | $426K | Buy |
1,538
+19
| +1% | +$5.37K | 0.03% | 159 |
|
|
2022
Q3 | $406K | Buy |
1,519
+26
| +2% | +$5.52K | 0.03% | 156 |
|
|
2022
Q2 | $304K | Sell |
1,493
-3
| -0.2% | -$613 | 0.02% | 177 |
|
|
2022
Q1 | $315K | Sell |
1,496
-85
| -5% | -$18.5K | 0.02% | 186 |
|
|
2021
Q4 | $379K | Sell |
1,581
-24
| -1% | -$6.17K | 0.02% | 171 |
|
|
2021
Q3 | $454K | Sell |
1,605
-98
| -6% | -$32.1K | 0.03% | 149 |
|
|
2021
Q2 | $590K | Buy |
1,703
+27
| +2% | +$8.18K | 0.05% | 118 |
|
|
2021
Q1 | $469K | Sell |
1,676
-1
| -0.1% | -$270 | 0.1% | 126 |
|
|
2020
Q4 | $411K | Sell |
1,677
-44
| -3% | -$11.4K | 0.1% | 129 |
|
|
2020
Q3 | $488K | Buy |
+1,721
| New | +$480K | 0.15% | 106 |
|
|
2019
Q2 | – | Sell |
-2,992
| Closed | -$707K | – | 170 |
|
|
2019
Q1 | $707K | Buy |
2,992
+91
| +3% | +$28.7K | 0.27% | 74 |
|
|
2018
Q4 | $873K | Buy |
2,901
+11
| +0.4% | +$3.51K | 0.4% | 59 |
|
|
2018
Q3 | $1.02M | Hold |
2,890
| – | – | 0.4% | 57 |
|
|
2018
Q2 | $839K | Hold |
2,890
| – | – | 0.34% | 65 |
|
|
2018
Q1 | $791K | Hold |
2,890
| – | – | 0.25% | 72 |
|
|
2017
Q4 | $921K | Sell |
2,890
-5
| -0.2% | -$1.6K | 0.3% | 62 |
|
|
2017
Q3 | $907K | Buy |
2,895
+130
| +5% | +$38.5K | 0.27% | 59 |
|
|
2017
Q2 | $750K | Hold |
2,765
| – | – | 0.22% | 66 |
|
|
2017
Q1 | $756K | Hold |
2,765
| – | – | 0.22% | 66 |
|
|
2016
Q4 | $784K | Buy |
+2,765
| New | +$820K | 0.22% | 62 |
|
|
2016
Q1 | – | Sell |
-2,765
| Closed | -$847K | – | 46 |
|
|
2015
Q4 | $847K | Hold |
2,765
| – | – | 1.01% | 22 |
|
|
2015
Q3 | $807K | Buy |
+2,765
| New | +$913K | 0.73% | 30 |
|
|
2015
Q2 | – | Sell |
-2,765
| Closed | -$1.17M | – | 80 |
|
|
2015
Q1 | $1.17M | Buy |
+2,765
| New | +$1.09M | 1.16% | 18 |
|
Other funds holding BIIB
AIM
AAMU
ADEF
GIA
NGM
Plancorp LLC's BIIB Position: Q2 2026 in Review
Plancorp LLC reduced its Biogen (BIIB) stake by 1.6% in Q2 2026, selling an estimated $5.36K and leaving 1,726 shares worth $361K. The position accounts for 0.01% of the portfolio, ranked #304.
Plancorp LLC first reported a position in BIIB in Q1 2015 and has held it in 37 quarters since. The position peaked at $1.17M in Q1 2015. 241 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Plancorp LLC held 1,726 shares of Biogen worth $361K as of Q2 2026.
- Plancorp LLC sold 28 Biogen shares in Q2 2026, an estimated $5.36K.
- Biogen made up 0.01% of Plancorp LLC's portfolio in Q2 2026, its #304 holding.
- Plancorp LLC first reported a position in Biogen in Q1 2015 and has held it in 37 quarters since.
- Plancorp LLC's Biogen position peaked at $1.17M in Q1 2015.
- 241 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Plancorp LLC's 13F filing for Q2 2026, filed 14 Jul 2026.